Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2025

May 6, 2025

31461_dirs_2025-05-06_2d7078d2-f24d-4fdf-bb8c-d5a538d0fc89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2025-05-05

Reporting Person: WALSH MATTHEW M (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-05 Common Stock P 11400 $8.82 Acquired 144484 Direct